HB316 is an abortion-restriction bill framed as an act “relating to the protection of unborn children.” It would amend Kentucky law to define key terms such as “abortifacient,” “pregnant,” “fertilization,” and “unborn human being,” and it would make the statute operative only if the U.S. Supreme Court reverses Roe v. Wade in whole or in part, or if a federal constitutional amendment restores Kentucky’s authority to prohibit abortion. Once triggered, the bill would prohibit knowingly administering, prescribing, mailing, selling, or otherwise providing an abortifacient or using an instrument or procedure with the specific intent to terminate an unborn human being’s life.
The bill creates criminal penalties for violations, including a Class D felony for most violators and a Class C felony, with higher fines, for “foreign senders” who mail, ship, or knowingly place abortifacients into commerce for use in Kentucky. It also includes exceptions for licensed physicians acting to prevent a pregnant woman’s death or serious permanent impairment of a life-sustaining organ, and for accidental or unintentional injury or death to the unborn human being during medical treatment. The measure expressly states that the pregnant woman herself cannot be criminally prosecuted under the section, and it preserves the use of contraceptives administered before pregnancy can be detected through conventional medical testing.
HB316 also creates a private civil cause of action allowing a pregnant woman who receives an abortifacient to sue a person or entity that knowingly or intentionally performs or attempts an abortion in violation of the section. Successful plaintiffs could recover injunctive relief, $10,000 per abortion, court costs, and attorney’s fees, while defendants would be barred from recovering fees or costs. In addition, the bill directs the Cabinet for Health and Family Services to place abortifacients, and abortion-inducing drugs defined elsewhere in Kentucky law, into Schedule IV under the state’s controlled substances framework.
The bill’s impact on state law would be significant: it would substantially expand Kentucky’s abortion prohibitions, add criminal and civil enforcement mechanisms, and alter drug scheduling rules for abortion-related medications. It would also interact with Medicaid funding rules by tying the section’s effectiveness to federal requirements governing when states must fund abortion to remain eligible for Medicaid funds. In practical terms, the bill would affect physicians, pharmacies, drug suppliers, out-of-state distributors, and patients seeking abortion-related medication or procedures in Kentucky.
No committee transcripts or recorded votes were provided, so there is no documented floor or committee debate to gauge sentiment directly. Based on the bill text alone, the measure is clearly designed to advance a strong anti-abortion policy position and would likely be supported by abortion opponents and opposed by abortion-rights advocates, medical providers, and reproductive health organizations. The main points of contention are likely to be the breadth of the abortion ban, the felony penalties for providers and remote suppliers, the civil lawsuit provision, and the inclusion of abortion-inducing drugs in controlled-substance scheduling.
HB316 would amend Kentucky’s abortion and controlled-substances statutes by creating a trigger-based abortion prohibition, criminal penalties for providers and suppliers, a private right of action for pregnant women, and a directive to schedule abortifacients and abortion-inducing drugs as controlled substances. It would significantly expand state enforcement against abortion medication and procedures, while preserving limited medical-emergency exceptions and excluding the pregnant woman from criminal liability.
No votes or committee discussion were provided, so there is no recorded legislative sentiment to summarize. From the bill text, the measure reflects a strongly anti-abortion policy approach and would likely be viewed favorably by abortion opponents and unfavorably by abortion-rights advocates, physicians, and reproductive health groups.
The most likely points of contention are the bill’s broad prohibition on abortion-related conduct, the felony penalties for providers and especially “foreign senders,” the private civil enforcement mechanism with statutory damages and fee shifting, and the requirement that abortifacients be placed into Schedule IV. Supporters would likely emphasize fetal protection and state authority, while opponents would likely argue that the bill intrudes on reproductive autonomy, burdens medical practice, and creates legal risk for medication access and interstate commerce.